Clinical trial details
Estimated Primary Completion Date :June 2024
versus
Announcements / News article above
H12023
I really doubt it will run on time for H12023, given recent Covid trials. Staff shortages etc.
we’ll see.
cheers
Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS, page-47
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
0.035(6.67%) |
Mkt cap ! $308.1M | |||
| Open | High | Low | Value | Volume |
| 51.5¢ | 57.3¢ | 50.5¢ | $2.179M | 3.991M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 30558 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |